Document Detail


Soluble Fas and Fas ligand and prognosis in children with acute lymphoblastic leukemia.
MedLine Citation:
PMID:  21528407     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The soluble forms of Fas and its ligand (sFas and sFasL) correlate with disease progression in various malignancies. We compared serum levels of sFas and sFasL in children with acute lymphoblastic leukemia and healthy children to determine the prognostic significance of these molecules. Serum levels of sFas and sFasL were measured with an enzyme-linked immunosorbent assay in 48 patients with newly diagnosed childhood acute lymphoblastic leukemia and 38 healthy children. Cut-off values of sFas and sFasL levels were based on their levels in controls. Clinical and laboratory characteristics were recorded on admission. The mean serum concentration of sFas was 243 ± 40 pg/mL in patients and 238 ± 29 pg/mL in controls. Serum levels of sFasL were 4.33 ± 0.25 ng/mL in patients and 4.27 ± 0.11 ng/mL in controls. Neither difference was significant. Based on the cut-off value, 12.5% of the patients were positive for sFas, and 16.6% were positive for sFasL. Survival was significantly longer in sFasL-positive patients (394 ± 69.6 vs. 254 ± 24.3 days) and the duration of complete remission was also longer (380 ± 65.0 vs. 246 ± 26.0 days) than in sFasL-negative patients (P < 0.02), indicating the important role of this molecule in the response to therapy. Higher sFas levels were associated with hepatosplenomegaly (P < 0.047). In conclusion, sFasL positivity was associated with a favorable outcome in ALL patients.
Authors:
Mina Fathi; Zahra Amirghofran; Mehdi Shahriari
Related Documents :
14652097 - Facilitation of motor evoked potentials in ischemic stroke patients: prognostic value a...
11940547 - Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tis...
18190817 - Identification of nonischemic stroke mimics among 411 code strokes at the university of...
19743467 - Circulating endothelial microparticles as a marker of cerebrovascular disease.
13426797 - The carcinolytic effect of actinomycin c; a report of clinical studies.
16609347 - Culture-positive and culture-negative endocarditis in patients with cancer: a retrospec...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-29
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  -     ISSN:  1559-131X     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Immunology, Shiraz Medical School, Medicinal and Natural Products Chemistry Research Center and Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, 71345-1798, Shiraz, Iran, minafathi30@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Small intestinal vascular malformation bleeding: diagnosis by double-balloon enteroscopy combined wi...
Next Document:  Classical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effecti...